Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Nuclear Corporation
Beijing, Beijing, China
- Ownership
- Private
- Employees
- ~180000
- Development stage
- Other
01
Overview
CNNC is the leading Chinese state-owned enterprise in the nuclear sector, providing nuclear fuel, constructing nuclear reactors, and producing radiopharmaceuticals and radioactive sources for medical purposes, with a market share of 70% in radioactive medicine in China. CNNC's primary business is in power and industry rather than traditional biotech or pharma clinical pipelines.[1][4]
- Modalities
- RadiopharmaceuticalRadioactive sourceDevice
- Industry
- Chemicals & Materials
02
Partnerships
International Atomic Energy Agency (IAEA)Tsinghua UniversityChina Huaneng Group
Beyond the preview
Go deeper on China National Nuclear Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China National Nuclear Corporation.